Squarepoint
TMDX icon

Squarepoint’s Transmedics TMDX Stock Holding History

Squarepoint’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,500
Closed -$729K – 4895
2025
Q3 		$729K Sell
6,500
-11,700
-64% -$1.37M ﹤0.01% 2921
2025
Q2 		$2.44M Sell
18,200
-6,100
-25% -$670K ﹤0.01% 1950
2025
Q1 		$1.63M Buy
+24,300
New +$1.67M ﹤0.01% 2257

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Squarepoint's TMDX Position: Q2 2026 in Review

Squarepoint sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 7,274 shares — an estimated $616K sold.

Squarepoint first reported a position in TMDX in Q2 2019 and held it in 23 quarters. The position peaked at $35.6M in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Squarepoint reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Squarepoint sold 7,274 Transmedics shares in Q2 2026, an estimated $616K.
  • Squarepoint first reported a position in Transmedics in Q2 2019 and held it in 23 quarters.
  • Squarepoint's Transmedics position peaked at $35.6M in Q3 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.